WILMINGTON, Mass. & DUBLIN--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is the first company to offer clients Good Laboratory Practices (GLP) ...
PRINCETON, NJ and DUBLIN, IRELAND / ACCESSWIRE / September 14, 2023 / Deciphex, a trailblazer in digitizing and networking global pathologists, has joined forces with Xybion, a global leader in ...
The Patholytix preclinical solution aids improved process efficiency in preclinical toxicology by adopting a unique pattern recognition approach LONDON, May 20, 2019 /PRNewswire/ -- Based on its ...
WILMINGTON, Mass. & DUBLIN--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leader in preclinical ...
DUBLIN--(BUSINESS WIRE)-- Deciphex, a leader in AI-powered digital pathology, has closed its Series C financing, raising $32.3 million to address the acute global pathology crisis. Led by Molten ...
WILMINGTON, Mass. & DUBLIN, April 11, 2024--(BUSINESS WIRE)--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Patholytix Foresight, a non-clinical artificial ...
"Deciphex's Patholytix Preclinical is an ergonomic, high throughput platform that uses big data and an optimised classification approach focused on whole-slide images," said Deepak Jayakumar, senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results